Safety and Efficacy of Low-Dose Regorafenib Combined with Nivolumab in Patients with Advanced HCC in Progression Beyond Two or More Lines of Tyrosine Kinase Inhibitors: Case Reports and Short Review of the Literature

Yasmina Ben Merabet, Astrid Laurent Bellue, Maïté Lewin, Catherine Guettier, Antoinette Lemoine-Corbel

Journal of Diagnosis &amp Case Reports（2024）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined